Analysen von Chris Shibutani

06.08.24 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
07.05.24 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
21.03.24 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
08.11.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
07.11.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
05.06.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
09.05.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
26.04.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
28.03.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
16.01.23 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
08.11.22 Pfizer Neutral Goldman Sachs Group Inc.
08.11.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
14.10.22 Pfizer Neutral Goldman Sachs Group Inc.
26.08.22 Pfizer Neutral Goldman Sachs Group Inc.
09.08.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
29.07.22 Pfizer Neutral Goldman Sachs Group Inc.
13.07.22 Pfizer Neutral Goldman Sachs Group Inc.
30.06.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
15.06.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
25.05.22 Pfizer Neutral Goldman Sachs Group Inc.
11.05.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
04.05.22 Pfizer Neutral Goldman Sachs Group Inc.
01.04.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
09.02.22 Pfizer Neutral Goldman Sachs Group Inc.
08.02.22 Pfizer Neutral Goldman Sachs Group Inc.
19.01.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
12.01.22 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
07.01.22 Pfizer Neutral Goldman Sachs Group Inc.
17.12.21 Pfizer Neutral Goldman Sachs Group Inc.
24.09.21 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.
23.09.21 BioNTech (ADRs) Neutral Goldman Sachs Group Inc.